Search Result Products - CapitalBio Technology Co., Ltd.

All Related Products Other Content

The Disease Susceptibility Genetic Test-Cardiovascular Protection This test bases on biochip technology, evaluate the risk of three thrombotic diseases from the perspective of genetics.
Folic Acid Utilization Ability Genetic Detection The genetic testing for folic acid utilization can understand the body's ability to utilize folic acid from the gene level, and to realize the personalized supplementation of folic acid, thereby preventing occurrence of disease.
Individualized Medication Guidance for Cancer (118 Genes) This test detects 136 genes, provides the correlation between gene mutations and targeted drugs and chemotherapy drugs based on clinical data, and assists doctors to formulate personalized medication guidance for patients.
The Disease Susceptibility Genetic Test-Thrombotic Disorders (5 Items) This test bases on biochip technology, evaluates the risk of five thrombotic diseases from the perspective of genetics.
Y Chromosome Microdeletion Gene Detection The spermatogenesis disorders caused by genetic factors such as chromosomal abnormalities and gene mutations account for more than 30%, of which the Y chromosome microdeletion is the second largest genetic factor leading to male infertility.
Individualized Medication Guidance for Cancer (800 Genes) This test detects 800 genes, helping doctors formulate professional and individualized treatment plans for patients.
The Disease Susceptibility Genetic Test-Diabetes (4 Items) This test bases on biochip technology, from the genetic point of view, assess the risk of type 2 diabetes and its complications, and the sensitivity of hypoglycemic drugs.
Tandem Mass Spectrometry Screening for Genetic Metabolic Diseases Tandem Mass Spectrometry (MS/MS) is a powerful technique for the analysis of complex mixtures such as body fluids, cell lysates or biopsies.
The Disease Susceptibility Genetic Test-Cardiovascular Disease (14 Items) This test bases on biochip technology, evaluate the risk of 14 cardiovascular and cerebrovascular diseases from the perspective of genetics and guide disease prevention.
DMD (Duchenne muscular dystrophy)/ BMD (Baker muscular dystrophy) Genetic Detection Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are neuromuscular disorders that primarily affect boys due to an X-linked mutation in the DMD gene, resulting in reduced to near absence of dystrophin or expression of truncated forms of dystrophin.
The Disease Susceptibility Genetic Test-Chronic Disease Package (34 Items) This test bases on biochip technology, evaluates the risk of 34 chronic diseases from the perspective of genetics, and provide guidance to disease prevention.
17 Common Single-gene Disorders 17 common single-gene disorders panel of CapitalBio use NGS combined with multi-method platform to detect common recessive genetic disease, multiple variant types are detected at one time.
The Disease Susceptibility Genetic Test-Chronic Disease Package (63 Items) This test bases on biochip technology, evaluates the risk of 63 chronic diseases from the perspective of genetics, and provide guidance to disease prevention.
Neuromuscular Disorders There are 1,314 genetic diseases included in this test, which can be divided into 5 categories: peripheral neuropathy, muscular dystrophy, myopathy, muscular neuropathy, muscular neuropathy, systemic neuropathy.
The Disease Susceptibility Genetic Test-APOE The test is based on biochip technology. By detecting two gene loci that determine APOE protein polymorphism, it evaluates its impact on the risk of cardiovascular and cerebrovascular diseases, metabolic diseases.